ERNA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ERNA has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company